Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Neurological Research|August 4, 2007
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patientsTetsuya Nagata, Isao Nagano, Mito Shiote, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 6, 2020
2',4'-BNA/LNA with 9-(2-Aminoethoxy)-1,3-diaza-2-oxophenoxazine Efficiently Forms Duplexes and Has Enhanced Enzymatic Resistance*Yuki Kishimoto, Osamu Nakagawa, Akane Fujii, et al.
Nature Neuroscience|April 17, 2007
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neuronsMakiko Nagai, Diane B Re, Tetsuya Nagata, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular DystrophyYuko Hara, Yoshitaka Mizobe, Shouta Miyatake, et al.
Neurological Research|June 9, 2006
Temporal profile of neural stem cell proliferation in the subventricular zone after ischemia/hypoxia in the neonatal rat brainMasanori Iwai, Tomoaki Ikeda, Takeshi Hayashi, et al.
Molecular Therapy. Nucleic Acids|November 3, 2018
NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular DystrophyNaoki Watanabe, Tetsuya Nagata, Youhei Satou, et al.
Molecular Therapy. Nucleic Acids|March 4, 2025
Effect of chemical modification on the exon-skipping activity of heteroduplex oligonucleotidesTakenori Shimo, Juri Hasegawa, Kotaro Yoshioka, et al.
Molecular Therapy. Nucleic Acids|October 19, 2023
Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotideNaoki Watanabe, Yuichiro Tone, Tetsuya Nagata, et al.
The Journal of Organic Chemistry|March 24, 2011
Synthesis of 2'-O-[2-(N-methylcarbamoyl)ethyl]ribonucleosides using oxa-Michael reaction and chemical and biological properties of oligonucleotide derivatives incorporating these modified ribonucleosidesTakeshi Yamada, Natsuki Okaniwa, Hisao Saneyoshi, et al.
The American Journal of Pathology|March 11, 2016
Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular DystrophyMutsuki Kuraoka, En Kimura, Tetsuya Nagata, et al.
Pageof 8